Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Aug;84(8):1354-1362.
doi: 10.1016/j.ard.2025.03.012. Epub 2025 May 3.

A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease

Affiliations
Observational Study

A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease

Martha Tsaliki et al. Ann Rheum Dis. 2025 Aug.

Abstract

Objectives: Diagnosis of Sjögren's disease (SjD) consists of clinical examinations that include invasive studies such as lower lip biopsies and blood collection to identify presence of serum autoantibodies. Salivary glands of patients with SjD are sites where antibody-secreting cells accumulate and secrete immunoglobulins. Many patients with dry manifestations who do not meet classification criteria are grouped as non-Sjögren's sicca (NSS) and are heavily understudied. We undertook this cross-sectional observational study to investigate the role of salivary autoantibodies as a diagnostic tool and determine presence of salivary autoantibodies in patients with NSS.

Methods: In this cross-sectional observational study, we screened whole unstimulated saliva from 446 subjects by direct enzyme-linked immunosorbent assays and capillary western blotting for anti-Ro60, anti-La, and rheumatoid factor (immunoglobulin (Ig)G and IgA) antibodies. All subjects were classified following the ACR/EULAR classification at the Oklahoma Medical Research Foundation Sjögren's Research Clinic.

Results: Patients with SjD were significantly more likely to have salivary antibodies compared with those with NSS and healthy control subjects. In this cohort, there were 88 subjects with NSS with seronegative profiles who had detectable salivary autoantibodies and objective measures of dryness.

Conclusions: Of these 88 subjects with NSS, we identified 75 subjects that had positive objective examinations of dryness and could belong to an early-onset SjD group. Alternatively, these 75 subjects with NSS could belong to a distinct phenotype of SjD that will remain seronegative while being saliva positive for anti-Ro60. These data showed a relationship between ocular and oral dryness and the presence of salivary anti-Ro60 antibodies in subjects with NSS.

PubMed Disclaimer

Conflict of interest statement

Competing interests MT reports financial support was provided by Alexander S Onassis Public Benefit Foundation. KAK reports financial support was provided by Sjogrens Syndrome Foundation. RHS reports financial support was provided by National Institutes of Health and consulting or advisory fees from Jenssen Pharmaceuticals, IQVIA, and Merck & Co. All other authors declare they have no competing interests.

References

    1. Negrini S, Emmi G, Greco M, et al. Sjogren’s syndrome: a systemic autoimmune disease. Clin Exp Med. Feb 2022;22(1):9–25. doi: 10.1007/s10238-021-00728-6 - DOI - PMC - PubMed
    1. Ramos-Casals M, Brito-Zeron P, Seror R, et al. Characterization of systemic disease in primary Sjogren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). Dec 2015;54(12):2230–8. doi: 10.1093/rheumatology/kev200 - DOI - PMC - PubMed
    1. Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sjogren’s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19. doi: 10.1186/s13293-015-0037-7 - DOI - PMC - PubMed
    1. Ramos-Casals M EULAR recommendations for the management of Sjogren’s syndrome with topical and systemic therapies. RMD Open. Jan 2020;79(1):3–18. doi: 10.1136/rmdopen-2019-001064 https://doi.org/10.1136/annrheumdis-2019-216114 - DOI - PubMed
    1. Vitali C, Del Papa N. Classification and diagnostic criteria in Sjogren’s syndrome: a long-standing and still open controversy. Ann Rheum Dis. Dec 2017;76(12):1953–1954. doi: 10.1136/annrheumdis-2017-211378 - DOI - PubMed

Publication types

LinkOut - more resources